Differences in Corticotropin-Releasing Hormone-Stimulated Adrenocorticotropin and Cortisol before and after Weight Loss
Jack A. Yanovski,
Susan Zelitch Yanovski,
Philip W. Gold and
George P. Chrousos
Developmental Endocrinology Branch, National Institute of Child
Health and Human Development (J.A.K., G.P.C.); Office of the Director,
The Warren Grant Magnuson Clinical Center (J.A.Y.); the Division of
Digestive Diseases and Nutrition, National Institute of Diabetes and
Digestive and Kidney Diseases (S.Z.Y.); and the Clinical
Neuroendocrinology Branch, National Institute of Mental Health
(P.W.G.), National Institutes of Health, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Jack A. Yanovski, M.D., Ph.D., National Institutes of Health, Building 10, Room 10N2621862, 9000 Rockville Pike, Bethesda, Maryland 20892-1862. E-mail: YANOVSKJ{at}CC1.NICHD.NIH.GOV
Little is known about the effects of intentional weight losson the
function of the hypothalamic-pituitary-adrenal (HPA)axis of obese
individuals. We studied the HPA axis of 34 healthyobese women (body
mass index, 40.2 ± 7.9 kg/m2) beforeand after a
21.0 ± 7.9-kg weight loss induced by a 26-weekweight loss
program that included 12 weeks of a 3350 kJ/day(800 Cal/day) liquid
formula diet, 6 weeks of gradual refeeding,and 6 weeks of caloric
stabilization at 50206280 kJ/day(12001500 Cal/day). Obese subjects
were evaluated twice:before caloric restriction and during the last 3
weeks of caloricstabilization with a 3-h evening 1 µg/kg ovine CRH
(oCRH)stimulation test. CRH-stimulated ACTH and cortisol values were
comparedto those of a control group of 12 normal weight women. Before
caloricrestriction, both ACTH and cortisol responses to oCRH were
similarin obese women and normal weight controls. Weight loss did not
significantlyalter the ACTH response to oCRH; however, the total
plasma cortisolresponse to oCRH decreased significantly with weight
loss (areaunder the curve, 96,320 ± 21,040 nmol/L·min before
weightloss; 82,450 ± 22,460 nmol/L·min after weightloss;
P < 0.001). Cortisol-binding globulin also
decreasedsignificantly after weight loss (2,270 ± 1,050 nmol/L)
comparedeither to values obtained before weight loss (3,590 ±
1,360nmol/L; P < 0.001) or to those of normal
weight controls(3,910 ± 1,400 nmol/L; P <
0.001). Assay for plasmafree cortisol, either before or 180 min after
oCRH treatment,showed no significant changes in cortisol responses
resultingfrom weight loss. As plasma free cortisol was not altered by
weightreduction, the decrease in the total cortisol response to oCRH
afterweight loss appears to be secondary to significant decreasesin
cortisol-binding globulin. We conclude that when obese womenlose large
amounts of weight with a 3350 kJ/day, very low energydiet, such weight
reduction does not significantly affect theHPA axis.
This article has been cited by other articles:
A. N. Vgontzas, S. Pejovic, E. Zoumakis, H.-M. Lin, C. M. Bentley, E. O. Bixler, A. Sarrigiannidis, M. Basta, and G. P. Chrousos Hypothalamic-Pituitary-Adrenal Axis Activity in Obese Men with and without Sleep Apnea: Effects of Continuous Positive Airway Pressure Therapy
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4199 - 4207.
[Abstract][Full Text][PDF]
M. Manco, J. M. Fernandez-Real, M. E. Valera-Mora, H. Dechaud, G. Nanni, V. Tondolo, M. Calvani, M. Castagneto, M. Pugeat, and G. Mingrone Massive Weight Loss Decreases Corticosteroid-Binding Globulin Levels and Increases Free Cortisol in Healthy Obese Patients: An adaptive phenomenon?
Diabetes Care,
June 1, 2007;
30(6):
1494 - 1500.
[Abstract][Full Text][PDF]
J. W. Tomlinson, J. S. Moore, P. M. S. Clark, G. Holder, L. Shakespeare, and P. M. Stewart Weight Loss Increases 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2711 - 2716.
[Abstract][Full Text][PDF]
D. S. Jessop, M. F. Dallman, D. Fleming, and S. L. Lightman Resistance to Glucocorticoid Feedback in Obesity
J. Clin. Endocrinol. Metab.,
September 1, 2001;
86(9):
4109 - 4114.
[Abstract][Full Text][PDF]
J. A. Yanovski, K. D. Miller, T. Kino, T. C. Friedman, G. P. Chrousos, C. Tsigos, and J. Falloon Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy
J. Clin. Endocrinol. Metab.,
June 1, 1999;
84(6):
1925 - 1931.
[Abstract][Full Text]